Why to get tested at DNA Labs India for HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test ?
Book Now
-
3500 Sample collection centers, Free Home Sample
collection for HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test in your city
-
Ranked India No1 DNA Test Lab for
HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test
-
Most Trusted Lab by doctors for HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test. Call 07941057551 to talk with Doctor to
get second opinion for free of cost
-
100% All Conversation are private and confidential Call 07941057551 to talk with doctor 100%
Accurate Test Results for HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test
HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test Cost 15000 Rs
HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test Details
HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test cost INR:15000 symptoms diagnosis
HLA (Human Leukocyte Antigen) - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE is a blood test that measures the amount of antibodies in the blood against certain antigens. This test is performed to determine the compatibility of a person's tissues for organ transplantation.
What is HLA?
HLA is a protein that is present on the surface of cells in the body and helps the immune system recognize the body's own cells. HLA is important in organ transplantation because the immune system can recognize foreign HLA proteins as "non-self" and attack them.
What is PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE?
PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE is a blood test that measures the amount of antibodies in the blood against certain HLA antigens. The test is performed by exposing the patient's blood to a panel of HLA antigens and measuring the amount of antibodies that bind to each antigen.
Why is HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test performed?
HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test is performed to determine the compatibility of a person's tissues for organ transplantation. The test is used to identify potential donors for organ transplantation and to determine the likelihood of a successful transplant.
What are the Symptoms of HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE?
There are no specific symptoms of HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE. The test is performed to determine the compatibility of a person's tissues for organ transplantation.
How is HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test performed?
HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test is performed by drawing a small amount of blood from the patient's arm. The blood is then sent to a laboratory for analysis. The results of the test are usually available within a few days.
What is the Cost of HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test?
The cost of HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test in India is approximately INR 15000.
Diagnosis
HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test is performed to determine the compatibility of a person's tissues for organ transplantation. The test is used to identify potential donors for organ transplantation and to determine the likelihood of a successful transplant.
Conclusion
HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test is an important blood test that is performed to determine the compatibility of a person's tissues for organ transplantation. The test is used to identify potential donors for organ transplantation and to determine the likelihood of a successful transplant. The cost of the test in India is approximately INR 15000. If you are considering organ transplantation, it is important to speak with your healthcare provider about the HLA - PANEL REACTIVE IgG ANTIBODIES (PRA) CLASS II QUANTITATIVE Test.
High PRA is associated with delayed graft function, high incidence of acute rejection and short graft survival.
